Description
Pomide 4 mg contains Pomalidomide, a third-generation immunomodulatory drug (IMiD) structurally related to thalidomide and lenalidomide. It is primarily prescribed for patients with multiple myeloma who have previously been treated with other therapies such as lenalidomide and proteasome inhibitors.
🔬 Mechanism of Action
Pomalidomide works through multiple mechanisms:
- Modulates immune system function
- Enhances T-cell and natural killer (NK) cell activity
- Inhibits tumor necrosis factor-alpha (TNF-α)
- Suppresses angiogenesis (formation of new blood vessels that support tumor growth)
As a result, it reduces myeloma cell proliferation and promotes cancer cell death.
💊 Indications
Pomide 4 mg is indicated for:
- Relapsed or Refractory Multiple Myeloma
- Used in combination with dexamethasone or other anti-myeloma agents
- 📌 Key Features
- Strength: 4 mg
- Dosage Form: Oral capsule
- Therapeutic Class: Immunomodulatory Agent (IMiD)
- Typical Regimen: 4 mg once daily for 21 days followed by 7 days off (28-day cycle), as prescribed
- Monitoring: Regular complete blood count (CBC) required due to risk of neutropenia
⚕️ Benefits
- Effective in patients resistant to prior therapies
- Enhances immune-mediated anti-tumor activity
- Oral therapy for convenient administration
- Improves progression-free survival when used in combination regimens
⚠️ Precautions
- Highly teratogenic — strict pregnancy prevention program required
- Risk of neutropenia, anemia, and thrombocytopenia
- Increased risk of thromboembolic events
- Fatigue and peripheral neuropathy may occur
- Use strictly under hematologist/oncologist supervision
Pomide 4 mg (Pomalidomide Capsules) is an advanced immunomodulatory therapy for relapsed or refractory multiple myeloma, offering improved disease control and extended treatment options when administered under expert medical care.
